Efficacy and Tolerability of Atenolol, Nifedipine and Their Combination in the Management of Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Tolerability of Atenolol, Nifedipine and Their Combination in the Management of Hypertension

Published:1988 Issue:Supplement 4 Volume:35 Page:29-35
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Stanley N. N.,Thirkettle J. L.,Varma M. P.S.,Larkin H.,Heath I. D.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of a new degradation product of nifedipine formed on catalysis by atenolol: A typical case of alteration of degradation pathway of one drug by another;Journal of Pharmaceutical and Biomedical Analysis;2014-02

2. Development of Tablets for Controlled Joint Release of Nifedipine and Atenolol;Drug Development and Industrial Pharmacy;1998-01

3. Mibefradil (Ro 40-5967): the first selective T-type Ca2+ channel blocker;Expert Opinion on Investigational Drugs;1997-05

4. Hypotensive Effects of YM430, a 1,4-dihydropyridine derivative, in spontaneously hypertensive rats and renal hypertensive dogs;JPN J PHARMACOL;1997

5. Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker;Journal of Hypertension;1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP